We're thrilled to share the development of the strategic partnership between Natoli Engineering and TaBlitz. Natoli Engineering, with over 50 years of excellence in tablet compression tooling, teams up with TaBlitz, a pioneer in drug development technology. Together, we're set to transform the pharmaceutical landscape by accelerating drug development like never before.
31 July 2024
On 18 and 19 September 2024, Ilmac will be held at the Expo Beaulieu Lausanne, Switzerland, bringing together decision-makers from the entire life sciences industry value chain
7 July 2024
A variety of factors like powder flow, material characteristics, compression pressure, turret speed, etc can affect tablet quality and production run time. Any resulting tablet defects can exacerbate production costs or even result in no product at all! Therefore, it’s necessary to characterise the tablet compression process to achieve robust tablets.
2 April 2024
Following the postponement of an in-person EMC2020 due to the pandemic, we’re delighted that EMC2024 is taking place from Sunday 25th August to Friday 30th August 2024 in Copenhagen. EMC2024 is the 17th of its kind and will bring the world of scientific imaging together in one of Europe’s most beautiful cities - Copenhagen, Denmark.
24 January 2024
IPT caught up with Peter O’Toole, president of the Royal Microscopical Society, to hear how his first few months as president have gone, his plans for the Society and how the field of microscopy might develop over the next few years
20 December 2023
Natoli engineering has made significant contributions to the pharmaceutical and nutraceutical industries. Specialising in tablet compression and encapsulation technology, innovative machines, tooling and solutions that enhance tablet and encapsulation manufacturing processes, Natoli has advanced manufacturing technologies and practices worldwide
24 September 2023
LASER COMPONENTS offers a comprehensive range of sources and detectors for medical applications, from advanced imaging to laser surgery. Light plays an extremely important role in all aspects of medicine. Looking beyond the visible spectrum, infrared can also play an important role, measuring the things we cannot see with the human eye.
Product Profile, 17 October 2024
LASER COMPONENTS is excited to provide updated information for our precision multi-wavelength VCSELs. Brightlaser offer extremely compact VCSEL modules with exceptional performance.
Product Profile, 24 September 2024
As photonic applications expand into new fields and markets, we must address the challenges of operating high sensitivity optical detectors in potentially harmful environments. This can include extreme temperatures, shock forces, vibration, radiation, or even the depths of outer space.
Product Profile, 4 September 2024
LASER COMPONENTS offers partially reflective optics; output couplers and beam splitters for CO2 lasers, designed to reflect a defined percentage of the incident light and transmit the remaining part. The reverse side is generally AR coated for 10.6um.
Product Profile, 27 August 2024
Photonic integrated circuits (PICs) are gaining traction as their potential in creating compact, cost-effective and robust photonic devices is apparent. As PICs gain popularity in telecom applications, data centres, and various types of sensors, the need for advanced testing equipment becomes critical.
Product Profile, 20 August 2024
1 November 2024 -- London, UK -- As a landmark event, FlyPharma Vienna 2024 has successfully wrapped, marking a pivotal gathering of industry professionals, expert speakers and delegates, from notable companies such as Sanofi, Takeda, Bayer, Amgen, Octapharma, Lufthansa, IATA, DHL, DoKaSch, Kühne + Nagel and more.
Press Releases, 1 November 2024
30 October 2024 -- Karlsruhe, Germany -- Romaco will take advantage of this year’s CIPM, China International Pharmaceutical Machinery Exposition, to show its key technologies for manufacturing and packing pharmaceutical solids. The one stop solutions supplier’s portfolio covers the entire process chain – from powder to pallet.
Press Releases, 30 October 2024
30 October 2024 -- California, US -- Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates announced a significant expansion in their quality control (QC) testing capabilities at their San Diego, CA biologics development and cGMP manufacturing site.
Press Releases, 30 October 2024
24 October 2024 -- Laupheim, Germany -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), today announced the construction of a new state-of-the-art buffer media station at its company headquarters in Laupheim.
Press Releases, 23 October 2024
17 October 2024 -- Manchester, UK -- Yourgene Health, a leading international molecular diagnostics group, announces that it has received accreditation under the new EU requirements of the in vitro diagnostic regulation (IVDR) for the Yourgene® Cystic Fibrosis Base assay. The Yourgene Cystic Fibrosis Base assay is a Class C in vitro medical device under IVDR and is intended for use by healthcare professionals within a molecular laboratory environment.
Press Releases, 16 October 2024
IPT speaks to Michael Ruch at TaBlitz about the use of AI in tablet design, why it’s effective and how it will develop in the future
Digital, 22 September 2024
Large language models can be useful in the pharmaceutical industry in order to streamline digital capabilities. However, steps must be taken in order to mitigate the phenomenon of AI hallucinations – incorrect and false data that can jeopardise a company’s data set
Digital, 22 September 2024
Pharma laboratories should be looking to innovative digital techniques such as data, AI and the cloud to aid drug discovery and research
Digital, 22 September 2024
AI, especially genAI, is becoming increasingly popular in the pharma and life sciences industries. How can companies use large language models – and more specifically, retrieval augmented generation architectures – to ensure AI-generated results are accurate?
Digital, 22 September 2024
Frailty should not be considered an inevitability, but the effects can be significant. How can technological innovations combat this?
Digital, 7 July 2024
In the fast-paced world of pharmaceutical manufacturing, efficiency and precision are non-negotiable. For manufacturers dealing with difficult-to-encapsulate powders and formulations, the Natoli NCF-45 Capsule Filling Machine emerges as a game changer. With the potential to pay for itself in the powder you’ll save, the NCF-45 isn’t just a machine, it’s an investment in better yields and greater profits. Better yields = better profits
There are usually two parameters important to pharmaceutical manufacturers: time and money. Is everything still on schedule? And are they still on budget? They need non-stop insight
Focusing on regulation within pharmaceutical manufacturing can help re-centre a company’s priorities, while ensuring compliance. This can be aided by the use of advanced monitoring techniques
Following good manufacturing practices (GMP) is crucial for stability testing. The analytical data generated from stability studies is a pivotal part of a regulatory dossier submission to substantiate the shelf life claimed for the drug product or drug substance and further support that shelf-life post-approval. All aspects of the stability study must be executed to the highest level of quality to ensure...
Protein-based immunotherapies, such as monoclonal antibodies and adoptive cell transfer therapies, are reshaping oncology treatments, but ensuring their safety and efficacy is crucial for their success
Medical devices should be designed with an awareness of the challenges of a specific disease as well as an awareness of equality, and the uk government has recently produced a new initiative around this, but how will this impact medical device production going forward?
Protein synthesis is the process by which cells build proteins, fundamental molecules necessary for virtually all cellular functions, but how can this be used within the discovery and manufacturing of new drugs and how can it be automated?
This article explores the significant opportunities within the biologics contract development and manufacturing organisation (CDMO) industry to optimize client satisfaction by meeting the critical demands of discerning clients. Six key facets are identified as pivotal to success, while underscoring the fundamental role of a client-centric approach and the importance of building and nurturing strong client relationships.
Robots are revolutionising manufacturing, but manual programming hampers their potential. Robot offline programming offers a digital solution, reducing human work hours by up to 80% and ensuring swift task readiness
In the post-covid-19 era, healthcare grapples with staff shortages and treatment delays, emphasising the need for early diagnosis. While regulatory changes pose challenges, eu extensions provide relief
Proteins govern crucial biological processes, making protein-protein interactions vital for understanding and treating diseases, peptide-based mimics offer tailored therapeutic approaches, yet optimising their efficacy poses challenges
After assessing the various routes of drug administration, oral delivery stands out as the safest and, as a result, the most universally accepted among patients. Single-unit dosage forms, including tablets followed by capsules, have been identified as the preferred designs for immediate or modified release formulations
Drug administration by inhalation is an established technique for treating respiratory and systemic diseases. Effective drug delivery to the lungs requires the aerosolisation and dispersion of a formulation into particles or droplets in the inhalable size range, typically an aerodynamic diameter below 5 µm. In many cases, particle engineering is used to optimise a formulation for efficacy
Refeyn discusses the challenges associated with AAV manufacture, the key analytical techniques currently used to facilitate insight into AAV samples and novel techniques striving to overcome current limitations
By seamlessly integrating a dynamic MES into digitisation road maps, companies have achieved greater operational efficiency, data integrity and harnessed real-time insights to meet their strategic goals
Natoli engineering has made significant contributions to the pharmaceutical and nutraceutical industries. Specialising in tablet compression and encapsulation technology, innovative machines, tooling and solutions that enhance tablet and encapsulation manufacturing processes, Natoli has advanced manufacturing technologies and practices worldwide
With the lab of the future becoming increasingly automated, how will this change workflows and how can the industry prepare for this?
The pharmaceutical sector is characterised by intricate processes, stringent regulations and a constant demand for innovation. However, the industry's digital transformation is hindered by the prevalence of legacy machinery, which often poses compatibility challenges when deploying new technology. COPA-DATA explains the method of standardisation to remove the barriers of integration of legacy equipment in labs and production lines
'Increasing economic challenges like market vitality, product diversification and cost pressure lead to the need for faster process design' − and that is not to mention the shorter innovation cycles and increasing demand for small batch production. The module type package suite from COPA-DATA meets these needs
Lab layouts, until the introduction of automation, had seen little change in decades. However, the increased usage of hardware and software lab automation has reduced repetitive manual tasks and drastically increased the walkaway time involved in experiments
Whether lab managers are enthusiastic or apprehensive, AI is coming to the lab. The key to building this advantage is not in the technology, but the approach. Successful adoption of AI requires a genuine, long-term commitment. IPT spoke to Bob Voelkner at LabVantage Solutions about the implications of AI for pharma, what it takes to succeed with this new technology and his five recommended steps for getting started
LabVantage Solutions’ Pharmaceutical LIMS is Engine for Digital Transformations
Healthcare and scientific facilities are critical for the health of the global population. During the COVID-19 pandemic, scientific facilities helped to deliver life-saving vaccines, re-emphasising their importance in achieving other scientific milestones in the coming decades
The digitalisation of pharmaceutical manufacturing has come a long way. However, there are still many ways companies can improve systems to grow even further
Pharmaceutical companies face plenty of challenges throughout the manufacturing cycle. Automation can be the key to bringing the industry to the forefront of this exciting field
IPT speaks to Toon Overbeeke of Vitestro about the potential benefits of using robots in clinics to draw blood from patients. With a shortage of clinical staff all over Europe, Toon believes robotics is the way forward regarding individual clinical patient care
IPT speaks to Mikael Hagstroem, CEO of LabVantage Solutions, about the ongoing potential for laboratories of adopting AI and machine learning (ML)
Smart automation is enabling new ways to monitor and intervene pre-emptively in pharma manufacturing. Find out the views of industry experts, who debated the subject in a roundtable video discussion.
The repercussions of events like Brexit and the global pandemic have caused uncertainty and a need to rethink strategy altogether. However, an integrated SaaS solution can provide a holistic view of the business and enhanced control over processes.
Considering the importance and cost associated with oligonucleotide-based therapeutics, how can innovative computing imaging techniques be used to aid in the process, while also creating an audit trail and increasing the data derived from these experiments?
Discovery and Development, 22 September 2024
Since the completion of the human genome project in 2003, there has been huge growth in the utilisation of genomics, but how can partnerships in this area be used to improve patient experience
Discovery and Development, 7 July 2024
Synthetic biology has been a cornerstone in recent health advancements, including drug discovery, development and manufacturing, however there are challenges facing this market
Discovery and Development, 7 July 2024
The development and use of novel gene therapy approaches is increasing. With the advent of innovative technologies using improved tropism and safer viral-based systems, and nanotechnology advancing non-viral delivery of nucleic acid vectors, there will be more gene-based products entering the market in near future
Discovery and Development, 18 March 2024
Ipt talks with jacob tesdorpf at revvity about the recent developments in preclinical imaging, from ai-enchanced analysis to refined disease models
Discovery and Development, 18 March 2024
Society recognises outstanding achievements in microscopy, imaging and flow cytometry
Analytics, 22 September 2024
Thermo fisher scientific discusses the role of process analytical technology in addressing the process challenges concerning fermentation and cell culture in biotechnology and enhancing quality and speed production
Analytics, 18 March 2024
Recent advancements in MALDI mass spectrometry imaging are transforming disease understanding and treatment. This innovation promises rapid diagnostics and personalised medicine, with reliable imaging within five years
Analytics, 18 March 2024IPT caught up with Peter O’Toole, president of the Royal Microscopical Society, to hear how his first few months as president have gone, his plans for the Society and how the field of microscopy might develop over the next few years
Analytics, 20 December 2023
IPT talks to Yama Abassi at Agilent about immunology and cell analysis and how these will develop in the future
Analytics, 20 December 2023
Droplet-based single-cell analysis systems provide an invaluable tool to accelerate research and development. Recent scientific advances enhance the applicability of these droplet-based systems to address the age-old problem of characterising, understanding and selecting cells
Analytics, 24 September 2023
3 September 2024 -- Lausanne, Switzerland -- Visitors can look forward to 18-19 September 2024 when Ilmac Lausanne becomes the biggest event for the chemical and life sciences industry in western Switzerland. At Expo Beaulieu Lausanne, more than 190 companies and associations will be exhibiting for the first time in the spacious Hall 36, whose 5,400 square metres are fully booked.
Conferences and Events , 9 September 2024
Arlington, VA—AAPS is proud to announce the recipients of the 2024 Awards Program. AAPS Awards celebrate scientists who are role models in the pharmaceutical science community. Each year, scientists volunteering through the AAPS Awards Committee review nomination submissions and select individuals whose scholarship, leadership, and service exemplify the highest personal and professional achievement.
Conferences and Events , 31 July 2024
Arlington, VA—AAPS is pleased to announce that eight members have been selected for elevation to Fellow status in recognition of their professional excellence and sustained superior impact in fields relevant to AAPS’ mission: advancing the capacity of pharmaceutical scientists to develop products and therapies that improve global health.
Conferences and Events , 31 July 2024
We are proud media partners of Elrig's Drug Discovery 2024!
Conferences and Events , 18 July 2024
Come and join us for the 13th edition of BioFIT, on December 3rd & 4th, 2024 in Lille and digital meetings days on December 11th & 12th, 2024!
Conferences and Events , 9 July 2024
Come and join us for the 13th edition of BioFIT, on December 3rd & 4th, 2024 in Lille and digital meetings days on December 11th & 12th, 2024!
IPT TV, 9 October 2024
Showcasing innovation, accelerating investment and facilitating partnering for life science leaders in Northern Europe.
IPT TV, 8 September 2024
Accelerate Your Therapeutics to Market: Expedite R&D, Improve CMC Efficiency & Build New Partnerships Join the industry’s leading event in Europe and access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies -- from discovery to market.
IPT TV, 4 September 2024
Join the world's leading orphan drug and rare disease Congress! 📅 22-25 October, 2024 📍Fira De Barcelona, Montjuic, Barcelona, Spain
IPT TV, 22 July 2024
Take a look at our trailer for the world's leading vaccine event! The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meetings of their kind across the globe since 2000.
IPT TV, 22 July 2024
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.
